Barrett's esophagus: pathogenesis, treatment, and prevention.
Barrett's esophagus: pathogenesis, treatment, and prevention.
复制标题
DOI：
10.1016/j.giec.2008.05.005
复制
发表时间：
2008-07-01
影响因子：
--
通讯作者：
Wang, Kenneth K
中科院分区：
文献类型：
--
作者：
Badreddine, Rami J;Wang, Kenneth K
食管腺癌是美国和西欧最常见的食管癌类型。Barrett食管（BE）是食管腺癌的一个众所周知的风险因素，据信在6%至12%接受胃食管反流病内镜检查的患者中发现，在所有接受内镜检查的患者中超过1%。本文着重介绍BE的发病机制、治疗和预防。
Esophageal adenocarcinoma is the most common type of esophageal cancer seen in the United States and Western Europe. Barrett's esophagus (BE) is a well-known risk factor for esophageal adenocarcinoma and is believed to be found in 6% to 12% of patients undergoing endoscopy for gastroesophageal reflux disease and in more than 1% of all patients undergoing endoscopy. This article focuses on the pathogenesis, treatment, and prevention of BE.